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Objectives. We hypothesized that atherectomy would be supe- 
rior to balloon angioplasty for ostial and nonostial left anterior 
descending coronary artery lesions. 
Background. Balloon angioplasty of ostial coronary artery 
lesions has been associated with a lower procedural success rate 
and a higher ate of complications and of restenosis than angio- 
plasty of nonostial stenoses. Directional coronary atherectomy 
has been proposed as an alternative therapy for ostial lesions. 
Methods. In the Coronary Angioplasty Versus Excisional 
Atherectomy Trial (CAVEAT-I), 1,012 patients were randomized 
to undergo either procedure; 563 patients had proximal left 
anterior descending coronary artery lesions, of which 74 were 
ostial. We compared balloon angioplasty with directional atherec- 
tomy for early and 6-month results for ostial as well as nonostial 
proximal left anterior descending coronary artery lesions. 
Results. Directional atherectomy led to an initially higher gain 
in minimal umen diameter for ostial lesions (1.13 vs. 0.56 mm, 
respectively, p < 0.001) but a higher ate of adjudicated non-Q 
wave myocardial infarction (24% vs. 13%, respectively, p < 0.001) 
than balloon angioplasty and no improvement i  restenosis rates 
(48% vs. 46%, respectively). In the nonostial proximal left anterior 
descending coronary artery lesions, angiographic restenosis was 
reduced (51% vs. 66%, p = 0.012), but this was also associated 
with a higher ate of periprocedural myocardial infarction (8% vs. 
2%, p = 0.008 by site and 24% vs. 8%, p < 0.001 by adjudication) 
and no difference in the need for subsequent coronary artery 
bypass urgery (7.3% vs. 8.4%, respectively) or repeat percutane- 
ous coronary intervention (24% vs. 26%, respectively). 
Conclusions. For ostial eft anterior descending coronary artery 
stenoses, both procedures yielded similar rates of initial success 
and restenosis, but atherectomy was associated with more non-Q 
wave myocardial infarction. In this trial the predominant angio- 
graphic benefit (increased early gain and less angiographic re- 
stenosis) of atherectomy for the left anterior descending coronary 
artery was in proximal nonostial lesions. However, the tradeoffs 
for this angiographic advantage were more in-hospital myocardial 
infarctions and no decrease in clinical restenosis. 
(J Am Coll Cardiol 1995;25:1380-6) 
Appropriate management of patients with proximal left ante- 
rior descending coronary artery stenoses represents a formida- 
ble challenge. Because of the large amount of myocardium at 
risk, the proximal eft anterior descending coronary artery 
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location is associated with a worse outcome than are other 
lesion locations (1,2). The European Coronary Surgery Study 
(3) found that the presence of proximal left anterior descend- 
ing coronary artery stenosis as a component of multivessel 
disease was the most powerful predictor of a significant benefit 
from early surgical revascularization. Similarly in an analysis of 
the determinants of outcome after multivessel angioplasty, the 
presence of proximal left anterior descending coronary artery 
stenosis was significantly correlated with a less favorable 
event-free survival rate (4). With the advent of new percuta- 
neous therapies, proximal eft anterior descending coronary 
artery stenoses have remained an important and difficult 
subgroup of lesions. In some studies (5) the proximal eft 
anterior descending coronary artery seems to have a proclivity 
for restenosis, and complications such as abrupt closure are 
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more serious because of the large amount of myocardium at 
risk. Ostial left anterior descending coronary artery stenoses, a
subset of these proximal lesions, are thought o have unique 
characteristics (6). Balloon angioplasty of ostial lesions has 
been associated with lower rates of initial success and higher 
rates of procedural complications and restenosis. For these 
reasons atherectomy has been advocated as a superior treat- 
ment for ostial lesions including left anterior descending 
coronary artery ostial lesions (7). In many centers, a lesion in 
the ostial left anterior descending coronary artery location 
constitutes an empiric indication for directional atherectomy. 
Using data from a large multicenter randomized trial, we 
compared angioplasty with atherectomy for ostial left anterior 
descending coronary artery lesions. Further, the results of 
intervention for ostial left anterior descending coronary artery 
lesions were compared with those of intervention for nonostial 
left anterior descending coronary artery lesions. We hypothe- 
sized that directional atherectomy would be a superior evas- 
cularization strategy for both segments of the proximal left 
anterior descending coronary artery, with fewer complications 
and less restenosis compared with balloon angioplasty. 
Methods 
Participating sites, investigators and patient population. 
A group of 35 participating sites enrolled 1,012 patients in the 
Coronary Angioplasty Versus Excisional Atherectomy Trial 
(CAVEAT-I) (8). Each operator was required to have per- 
formed >400 coronary angioplasty procedures with a success 
rate >85% and >50 athcrectomy procedures with a success 
rate >80%. Our study group comprised all patients with a left 
anterior descending coronary artery target lesion who were 
enrolled in this trial. Details of the study protocol have been 
published previously (8). Briefly, eligible patients were those 
who had symptomatic schemic heart disease with de novo, 
focal (<12 mm) coronary atherosclerotic lesions deemed 
suitable for either percutaneous transluminal coronary angio- 
plasty or directional coronary atherectomy and who were 
willing to give informed consent for the study. These patients 
were assigned randomly to directional atherectomy or angio- 
plasty. For cases in which multiple lesions were treated, a 
single lesion was designated as the "target lesion." 
Revascularization procedures. By protocol the goal of the 
coronary intervention was an angiographic result with as little 
residual stenosis as possible; a value of 20% diameter stenosis 
was the stipulated objective. Technical success was defined 
conventionally asa residual stenosis of <50%. Cross-over to 
the other treatment method was strongly discouraged. At the 
beginning and end of each procedure a coronary angiogram of 
the target vessel was obtained in two orthogonal views with 
either a 7F or an 8F catheter. Intracoronary nitroglycerin (100 
to 200 /xg) was given first to standardize the quantitative 
coronary angiography. Systematic follow-up coronary angiog- 
raphy was performed at 6 months, matching the orthogonal 
and hemiaxial views used during the index procedure. 
Each patient received aspirin and at least one dose of a 
calcium channel blocking agent before the procedure. Heparin 
was administered to maintain the activated clotting time 
>300 s. A 12-lead electrocardiogram (ECG) was obtained 
before and within 24 h of the procedure. Creatine kinase (CK) 
levels with myocardial isoenzymes were measured every 12 h 
after the procedure for a total of two samples. Aspirin 
(325 rag/day) and a calcium channel blocker were prescribed 
for at least 1 month after the procedure. 
Angiographie laboratory. The cineangiograms were for- 
warded to the laboratory of the Cleveland Clinic Foundation 
for independent blinded assessment ofthe initial and follow-up 
quantitative coronary angiograms. These assessments were 
made from the paired initial and follow-up angiograms with 
the technicians unaware of the treatment assignment and with 
any images that showed the procedural devices removed. The 
most severe view of the stenosis was selected for analysis, 
End-diastolic ine frames were digitized with a cine-video 
converter and a computer-assisted edge-detection algorithm 
(8). 
Definitions. An ostial eft anterior descend&g coronary artery 
lesion was defined as a stenosis of at least 60% on visual 
assessment within 3 mm of the origin of the left anterior 
descending coronary artery. Myocardial infarction (Q or non-Q) 
was defined in two ways. The first was a myocardial infarction 
diagnosed clinically at the participating site as reported in the 
case report forms and source medical records. The second type 
of myocardial infarction was determined by an adjudication 
committee at the Coordinating Center with no awareness of 
the assigned treatment. The adjudication committee members 
based their diagnosis on the development of new ECG changes 
and elevation of CK myocardial band isoenzyme l vels to at 
least two times normal, or elevation of CK levels at least to 
three times normal. Restenosis was defined as a ->50% stenosis 
at 6 months after an initially successful procedure. Patients 
were excluded from the restenosis analysis if the initial proce- 
dure was unsuccessful or if they died before a follow-up 
catheterization could be performed. 
Statistical analysis. All data are presented as median 
(25th, 75th percentiles) for continuous variables and number 
(%) for categoric variables. The 6-month rates are Kaplan- 
Meier survival rates (Table 6). Hypotheses of interest were 
specified for a select group of outcomes before data analysis. 
Thesc hypotheses included the following two principal issues: 
1) Ostial left anterior descending coronary artery lesions have 
a worse outcome than nonostial lesions, and 2) atherectomy 
leads to less restenosis of ostial esions compared with balloon 
angioplasty. To control for the experiment-wise type 1 error 
rate, we formally tested only the prespecified set of outcomes 
of primary interest using appropriate statistical tests. All other 
comparisons were evaluated informally using descriptive sta- 
tistics. 
The binary outcomes of angiographic success, restenosis 
and the in-hospital clinical outcomes were evaluated using 
logistic regression modeling techniques. Models were first 
developed using the predictor variables of treatment, left 
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Table 1. Baseline Clinical and Angiographic Characteristics 
Ostial LAD Nonostial LAD 
DCA PTCA DCA PTCA 
(n 41) (n - 33) (n = 250) (n = 239) 
Age (yr) 59 (48, 69) 58 (53, 65) 58 (51, 66) 59 (51, 67) 
Male gender 33 (8092) 24 (73 %) 190 (76%) 165 (69%) 
Weight (kg) 67 (66, 85) 83 (76, 88) 82 (73, 91) 81 (71, 92) 
Height (cm) 173 (165, 176) 173 (168, 177) 173 (167, 178) 173 (165, 178) 
Diabetes 6 (15~)~) 6 (18%) 46 (18%) 51 (21%) 
Current smoker 8 (20~5~) 9 (27%) 68 (27%) 55 (23%) 
Hypertension 20 (49%) 17 (52%) 134 (54%) 135 (56%) 
Hypercholesterolemia 21 (5i%) 13 (39%) 113 (45%) 102 (43%) 
Cholesterol (mg/dl) 222 (201,244) 198 (181,234) 218 (191,252) 212 (191, 251) 
History of MI 19 (46f,~) 12 (36%) 99 (40%) 95 (40%) 
Unstable angina 26 (63%) 22 (67%) 168 (67%) 170 (71%) 
Pain at rest 9 (35e)c) 9 (41%) 72 (43%) 73 (43%) 
Pain with ECG changes 2 (89k) 5 (23%) 47 (28%) 37 (22%) 
Angina after MI 6 (23~'~) 5 (23%) 22 (13%) 23 (14%) 
Accelerating pattern 16 (62¢t) 12 (55%) 110 (65%) 108 (64%) 
Ejection fraction (%) 58 (510, 65) 55 (50, 60) 60 (50, 65) 60 (50, 65) 
No. of diseased vessels 
1 27 (66%) 23 (709~-) 181 (73%) 171 (72%) 
2 14 (349/) 6 (18%) 58 (23%) 63 (26%) 
3 0 4 (12¢41 10 (4%) 5 (2%) 
Thrombus 9 (23~) 5 (15c4) 45 (18%) 37 (16%) 
Lesion length (mm) 7.4 (4.7, 10.3) 6.3 (4.6, 8.3) 8.8 (6.5, 11.2) 8.9 (6.6, 11.7) 
Vessel caliber (mm) 2.5 (2.2, 2.9) 2.4 (2.1, 2.8) 2.6 (2.3, 3.0) 2.6 (2.3, 2.9) 
% Stenosis 72 (61, 76) 61 (55, 73) 70 (63, 76) 71 (61, 78) 
Continuous measures are expressed as median (25th, 75th percentiles), calegoric variables as number (%) of patients. DCA - directional coronary atherectomy; 
ECG = electrocardiographic; LAD = left anterior descending coronary artery lesions; MI = myocardial infarction; PTCA = percutaneous transluminal coronary 
angioplasty. 
anterior descending coronary artery lesion type and the inter- 
action of treatment with lesion type. The importance of the 
interaction was tested first to determine whether the treatment 
effect was different for patients with ostial lesions versus 
nonostial lesions. This term was not significant for all models, 
implying that the treatment effect was statistically comparable 
in the two lesion groups. The final logistic models therefore, 
included as predictors a term for the treatment effect and one 
for the left anterior descending coronary artery lesion type. 
The p values presented for these outcomes reflect he signifi- 
cance of the predictor factors from these logistic models. The 
differences in clinical outcomes were tested for two left ante- 
rior descending coronary artery groups without categorization 
by treatment using chi-square analysis. 
The continuous quantitative angiographic outcomes, in- 
cluding 6-month minimal umen diameter, early gain and late 
loss, were evaluated using general linear modeling techniques. 
The three factors included in the model were again treatment, 
left anterior descending coronary artery lesion type and the 
interaction of the two. This interaction also was nonsignificant 
so the final models included the two main variables of treat- 
ment and lesion type. 
The differences in event rates up to 6 months were tested 
using Cox proportional hazards techniques. All events were 
censored at 6 months, allowing a test of differences only to that 
time. The modeling technique used was similar to others 
described. The interaction of treatment with lesion type was 
evaluated first and again found to be nonsignificant inall cases. 
The final model contained the predictor variables of treatment 
and lesion type. 
Results  
Clinical and angiographic features. A total of 1,012 pa- 
tients were entered and assigned randomly to directional 
coronary atherectomy or balloon angioplasty. A subgroup of 
563 patients had left anterior descending coronary artery 
target lesions. Of this group 74 patients had ostial left anterior 
descending coronary artery lesions. In the cohort with ostial 
lesions, 41 patients were assigned to directional atherectomy 
and 33 to conventional ngioplasty. A total of 489 patients had 
nonostial left anterior descending coronary artery lesions; 250 
of these patients were randomized to directional atherectomy 
and 239 patients to balloon angioplasty. Baseline clinical and 
angiographic features of these groups are summarized in Table 
1. These data show the effectiveness of randomization for this 
subgroup, with similar demographic and angiographic charac- 
teristics. Procedural characteristics are presented in Table 2. 
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Table 2. Procedural Features 
Ostial LAD Nonostial LAD 
DCA PTCA DCA PTCA 
(n 41) (n - 33) (n = 250) (n - 239) 
Maximal size of equipment 
Atherectomy catheter 
5F 0 
6F 19 (48%) 
7F 21 (52%) 
Balloon catheter (ram) 
<3.0 
3.0-3.99 
->4.0 
Use of opposite technique 11 (27%) 
Use of perfusion balloon 1 (2%) 
Stent or laser use 0 
Perforation 2 (5%) 
3 (9%) 
27 (85%) 
2 (6%) 
2 (6%) 
4112%) 
0 
0 
2(1%) 
133 (55%) 
106 (44%) 
76 (30%) 
26 (10%) 
2(1%) 
0 
23 (10%) 
199 (84%) 
13 (6%) 
9 (4%) 
28 (12%) 
o 
1 (0.4%) 
Data presented are number (%) of patients. Abbreviations as in Table 1. 
The differences in use of the opposing technique (cross-over) 
are similar to those of the overall population in CAVEAT-I 
(8). 
Angioplasty versus atherectomy for ostial left anterior 
descending coronary artery lesions. Initial procedural success 
rates were similar for the treatment groups (Table 3). Atherec- 
tomy resulted in a twofold larger early gain in minimal lumen 
diameter (1.13 vs. 0.56 mm for balloon angioplasty, with a 
residual stenosis of 26% for directional atherectomy versus 
39% for balloon angioplasty). Despite the apparently superior 
initial results for atherectomy in terms of early gain and 
residual stenosis, other results were nearly identical for the two 
procedures: the rate of restenosis by the binary dichotomous 
definition (48% for directional atherectomy vs. 46% for bal- 
loon angioplasty), the 6-month minimal lumen diameter (1.28 
vs. 1.25 ram) and the 6-month percent stenosis (49% vs. 50%) 
(Table 3). As shown in Table 4, there were no apparent 
differences in the rates of major acute complications (death, 
myocardial infarction or emergency bypass surgery) between 
the groups, although scrutiny of the cardiac enzymes revealed 
more non-Q wave myocardial infarction events in the direc- 
tional atherectomy group. 
Angioplasty versus atherectomy for nonostial eft anterior 
descending coronary artery lesions. As seen in Table 3 initial 
procedural success was improved with directional atherectomy 
compared with balloon angioplasty (91% vs. 78%, p < 0.001). 
At 6-month follow-up there was significantly less restenosis by 
the binary definition in the group who had atherectomy 
compared with those who underwent balloon angioplasty 
(51% vs. 66%, p = 0.012). As an angiographic orrelate of the 
lower rate of restenosis at 6 months, the minimal lumen 
diameter at 6 months was greater, though not significantly, for 
Table 3. Angiographic Core Laboratory. Results 
Ostial LAD 
DCA PTCA 
(n = 41) (n - 33) 
Nonostial LAD p Value* 
DCA PTCA 
(n = 250) (n - 239) Treatment LAD Type 
Success 32 (86%) 
Minimal lumen diameter 
Preprocedure 0.80 (0.62, 1.05) 
Postprocedure 1.96 (1.70, 2.18) 
6-too follow-up 1.28 (0.89, 1.87) 
Early gain 1.13 (0.75, 1.27) 
Late loss 0.66 (0.21, 1.06 
% Stenosis 
Preprocedure 72 (61, 76) 
Postprocedure 
QCA 26 (15, 35) 
Site 20 (10, 25) 
6-too follow-up 49 (33, 64) 
Restenosis 15 (48%) 
26 (87%) 221 (91%) 177 (78%) < 0.001 0.745 
1.04 (0.68, 1.19) 0.80 (0.6l, 1.02) 0.79 (0.60, 1.03) 
1.58 (1.43, 2.10) 1.83 (1.50, 2.111) 1.57 (1.33, 1.83) 
1.25 (0.93, 1.65) 1.33 (0.87, 1.70) 1.11 (0.84, 1.45) 0.679 0.026 
0.56 (0.38,/).98) 0.99 (0.61, 1.28) 0.76 (0.48, 1.04) 0.418 < 0.001 
0.22 (0.02, 0.57) 0.54 (0.14, 0.93) 0.49 (0.13, 0.79) 0.409 0.045 
61 (55, 73) 70 (63, 76) 71 (61, 78) 
39 (28,46) 33(25,41) 40(33,49) 
20110,33) 15 (2,20) 20(10,30) 
50(35, 74) 53 (37,68) 58(45, 68) 
12 (46%) 96 (51%) 100 (66%) 0.012 0.148 
*Presented for only a subset of these end points; statistical tests were performed only on prespecified hypotheses. Continuous measures are expressed as median 
(25th, 75th percentiles), categoric variables as number (%) of patients. QCA quantitative coronary angiography; other abbreviations as in Table 1. 
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Table 4. In-Hospital Outcomes for Ostial Versus Nonostial Left Anterior Descending Coronary Artery Lesions and by Treatment Assignment 
Ostial LAD Nonostial LAD p Value* 
DCA PTCA DCA PTCA 
(n = 41) (n - 33) (n - 250) (n 239) Treatment LAD Type 
Death 0 0 1) 2 (0.8%) 0.148 0.599 
MI (by site) 3 (7%) 2 (6%) 20 (8%) 5 (2%) 0.008 0.617 
Q wave I (27/~) 0 0 5 (2%) 0.008 0.927 
Non-Q wave 2 (5%) 2 (6%) 15 (6%) 3 (1%) 0.021 0.527 
MI by adjudication 8 (24%) 4 (13%) 54 (24%) 16 (8%) < 0.001 0.612 
Emergency CABG 2 (5%) 1 (3%) 4 (2%) 5 (2%) 0.878 0.229 
Composite: Death, 4 (10%) 3 (9%) 23 (9%) 8 (3%) 0.017 0.360 
MI (site) or CABG 
Data presented are number (%) of patients. *Treatment effect and type of lesion (ostial vs. nonostial) were evaluated using logistic modeling techniques; p values 
expressed are for the multivariable tr atment effect and lesion type ffect from these models. CABG = coronary artery bypass graft; other abbreviations as in Table 1. 
those patients who underwent directional atherectomy (1.33 
vs. 1.11 ram). 
There was a significant difference in periprocedural myo- 
cardial infarction (Table 4) for the nonostial left anterior 
descending coronary artery lesions. By clinical site report, 
atherectomy led to a higher rate of myocardial infarction (8% 
vs. 2%, p = 0.008), mainly non-Q wave myocardial infarction 
(6% vs. 1%, p = 0.02), and this was substantiated by a twofold 
increase in the adjudicated myocardial infarction rate (24% vs. 
8%, p < 0.001). 
Ostial versus nonostial left anterior descending coronary 
artery stenoses. Table 5 compares percutaneous interventions 
(balloon angioplasty and directional atherectomy) for ostial 
versus nonostial eft anterior descending coronary artery ste- 
noses. There were no significant differences in the rates of 
procedural success, in-hospital complications and restenosis. 
Comparison of angioplasty for 33 ostial left anterior de- 
scending coronary artery lesions and for 237 nonostial left 
anterior descending coronary artery lesions (Table 3) revealed 
a higher angiographic success rate for ostial lesions (86% vs. 
78%) and less frequent restenosis in ostial lesions treated with 
angioplasty (46% vs. 66%), but these differences were not 
statistically significant. 
Comparison of atherectomy for the 41 ostial left anterior 
descending coronary artery lesions and for 250 nonostial 
lesions showed similar angiographic success rates of 86% and 
Table 5. In-Hospital Outcomes for Ostial Versus Nonostial Left 
Anterior Descending Coronary Artery Lesions 
Ostial LAD Nonostial LAD 
(n 74) (n = 489) p Value 
Success 58 (87%) 398 (85%) 0.69 
Restenosis 27 (47%) 196 (57%) 0.16 
Death 0 2 ((I.4%) 1.00 
MI (by site) 5 (7%) 25 (5%) 0.56 
Emergency CABG 3 (4%) 9 (29;.) 0.22 
Death, MI (site) or 7 (9%) 31 (69;) 0.32 
CABG 
Data presented are number (%) of patients. Abbreviations as in Tables I and 4. 
91%, respectively. Restenosis rates were also similar for the 
two locations (48% vs. 51%). 
Clinical outcomes at 6 months. At 6 months there were no 
significant differences between the treatment groups in the 
rates of death, myocardial infarction, need for coronary artery 
bypass surgery or need for subsequent coronary intervention 
(Table 6). For ostial lesions the rates were 63% for atherec- 
tomy and 58% for angioplasty. Overall for nonostial esions, 
66% of the patients in the directional atherectomy group had 
no adverse clinical outcome at 6 months, compared with 67% 
of the patients who had balloon angioplasty. For this coronary 
segment there was an excess of myocardial infarction (as 
diagnosed clinically by the sites) at 6-month follow-up in the 
patients who had directional atherectomy. 
Discuss ion  
Our findings provide some new insights in the approach to 
patients with proximal left anterior descending coronary artery 
disease who are candidates for nonsurgical revascularization. 
Contrary to expected findings, this analysis of patients with 
ostial and proximal left anterior descending coronary artery 
lesions who were randomized to treatment with either direc- 
tional coronary atherectomy or balloon angioplasty shows no 
significant advantage for directional atherectomy. A preexist- 
ing bias that atherectomy is preferred for ostial left anterior 
descending coronary artery lesions is evident in the systematic 
exclusion of patients with these stenoses from the Canadian 
Coronary Atherectomy Trial (CCAT) (9). In designing the 
present rial, some participating investigators strongly believed 
that it would not be appropriate to assign patients randomly 
with ostial left anterior descending coronary artery stenoses. 
Paradoxal findings on the ostial left anterior descending 
coronary artery. The initial report from CAVEAT-I sup- 
ported improved 6-month angiographic outcomes for atherec- 
tomy in the subgroup of patients with proximal eft anterior 
descending coronary artery stenoses, which included those 
with ostial lesions. Patients with proximal left anterior de- 
scending coronary artery lesions had a significantly lower rate 
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Table 6. Cumulative Outcomes at6-Month Follow-Up for Patients With Ostial and Nonostial Left Anterior Descending Coronary Artery 
Target Lesions* 
Ostial LAD Nonostial LAD p Valuer 
DCA PTCA DCA PTCA 
(n ~ 41) (n : 33) (n 250) (n 239) Treatment LAD Type 
Death 1.000 1.000 0.980 0.992 0.296 0.994 
MI (site) 0.902 0.909 0.916 0.971 0,022 0.264 
CABG 0.902 0.818 0.927 0.916 0,380 0.085 
Need for subsequent onsurgical 0.683 0.697 0.757 0.740 0.704 0.238 
coronary intervention 
No adverse clinical event 0.634 {).576 U.660 0.674 0.769 0.264 
*All rates are Kaplan-Mcier 6-month survival rates, tDifferences in the treatment effect and ty, pe of lesion (ostial vs. nonostial) were assessed multivariably using 
Cox proportional hazards modeling techniques; p values expressed are of treatment effect and of lesion type from these models. Abbreviations as in Tables 1 and 4. 
of restenosis (51 for directional atherectomy vs. 63% for 
balloon angioplasty, p = 0.04) and a larger minimal lumen 
diameter 6 months after atherectomy (1.32 vs. 1.12 ram, p = 
0.008) (8). However, the present report clarifies this issue and 
clearly demonstrates that the patients with ostial left anterior 
descending coronary artery lesions had nearly identical resten- 
osis rates and 6-month minimal uminal diameters. The rates 
of restenosis n this trial were high relative to previous tudies, 
but unlike most investigators we used a worst-view quantitative 
angiographic standard (20). Nevertheless, the benefit of 
atherectomy in terms of restenosis and 6-month minimal 
lumen diameter isconfined to proximal nonostial left anterior 
descending coronary artery lesions. 
For the nonostial group the benefit was purely angio- 
graphic, with significant improvement in 6-month minimal 
lumen diameter and in the binary restenosis rate for the 
patients who had atherectomy. Unfortunately, this anglo- 
graphic benefit did not correlate with a significant change in 
clinical restenosis at 6 months and was achieved at a cost of 
significantly increased periprocedural myocardial infarction. 
Bigger is not necessarily better. It is interesting toexamine 
the data for ostial left anterior descending coronary artery 
lesions in terms of the "bigger is better" hypothesis of Kuntz et 
al. (10-14) and Fishman et al. (15). Although few lesions were 
examined, atherectomy did result in a twofold greater early 
gain (on average) in minimal lumen diameter. Despite the 
larger initial gains noted with atherectomy, there was no 
significant difference in restenosis and the average 6-month 
follow-up minimal umen diameter was identical for the two 
procedures. The data appear to confirm the expectation that 
one may achieve a superior angiographic result in the cathe- 
terization laboratory acutely with atherectomy, but in the case 
of ostial eft anterior descending coronary artery lesions, there 
is a fully compensatory increase in late loss (threefold for 
atherectomy vs.angioplasty) and no angiographic evidence of 
any lasting benefit at 6 months. 
Another major question addressed by this study is whether 
ostial left anterior descending coronary artery lesions repre- 
sent a distinct group such that expected success, complication 
and restenosis rates would be different from those for nonostial 
lesions. Percutaneous therapy of ostial stenoses has been 
associated with lower rates of success, more procedural com- 
plications and higher estenosis rates than that for nonostial 
lesions (6). This study unexpectedly found none of these 
differences when ostial eft anterior descending coronary artery 
lesions treated with angioplasty and atherectomy were com- 
pared with nonostial left anterior descending coronary artery 
lesions treated with angioplasty and atherectomy. Many of the 
reports associating ostial lesions with a poor outcome have 
been series of right coronary artery ostial lesions (16,17) or 
ostial vein graft stenosis (18,19), or combinations of different 
ostial lesions (7,21). It appears that success, complication and 
restenosis rates for ostial left anterior descending coronary 
artery lesions are relatively favorable when compared with 
rates for aorto-ostial lesions. 
Optimizing therapy for ostial lesions. Further study is 
needed to determine the optimal therapy for ostial eft anterior 
descending coronary artery lesions. Both balloon angioplasty and 
directional therectomy have high rates of restenosis, which may 
be exaggerated in the current trial because of the use of a 
worst-view quantitative angiographic index (20). With only 74 
patients with ostial left anterior descending coronary artery 
lesions in the current study, the statistical power was limited to 
detect even moderate differences between the treatment groups. 
More aggressive atherectomy, currently being assessed in a mul- 
ticenter randomized trial (Balloon Versus Optimal Atherectomy 
Trial [BOAT]), may yield different results. Coronary artery bypass 
surgery should be maintained as an alternative to percutaneous 
therapy. A recent randomized trial of balloon angioplasty versus 
internal mammary artery grafting for proximal eft anterior 
descending coronary artery stenoses (22) found that patients who 
had surgery had similar clinical and functional class improvement 
and wcre more likely to be free from subsequent surgical or 
percutaneous revascularization at 2.5 years. Recent randomized 
trials of elective stenting of the proximal left anterior descending 
coronary artery also raise the possibility that this strategy is 
advantageous forthis important coronary artery segment (23,24). 
Summary. The present study shows no advantage of direc- 
tional atherectomy over balloon angioplasty for ostial left 
anterior descending coronary artery lesions and a higher 
pcriprocedural myocardial infarction rate with atherectomy. 
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For nonostial eft anterior descending coronary artery lesions 
athereetomy was associated with a clear-cut reduction of 
angiographic restenosis. However, the angiographic advantage 
in nonostial esions was offset by a significantly higher rate of 
periprocedural myocardial infarction. These findings empha- 
size the ability of directional atherectomy to improve angio- 
graphic outcomes in a specific coronary artery segment--the 
nonostial proximal left anterior descending--but there is no 
accompanying evidence of clinical benefit. 
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